Nuvation Bio financials
$5.62+0.36%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $31.7M | $83.2M | $41.9M | $13.1M | $4.8M | $3.1M | $5.7M | $727.0K | $1.4M | $0.00 | $0.00 | $0.00 |
| Gross profit | $23.1M | $77.6M | $41.4M | $9.8M | $2.4M | $990.0K | $1.5M | -$788.0K | $88.0K | $0.00 | $0.00 | $0.00 |
| Gross margin | 73.0% | 93.3% | 99.0% | 74.5% | 50.3% | 32.1% | 26.2% | −108.4% | 6.1% | — | — | — |
| Operating income | -$51.0M | $3.9M | -$33.5M | -$56.6M | -$63.6M | -$59.0M | -$53.2M | -$48.3M | -$470.4M | -$20.2M | -$20.1M | -$26.6M |
| Net income | -$62.8M | $5.4M | -$36.6M | -$55.8M | -$59.0M | -$53.2M | -$49.4M | -$41.2M | -$462.5M | -$14.8M | -$13.8M | -$19.6M |
| Net margin | −198.3% | 6.5% | −87.4% | −425.2% | −1220.9% | −1726.2% | −865.8% | −5668.5% | −32229.4% | — | — | — |
| Diluted EPS | $-0.18 | $0.01 | $-0.11 | $-0.16 | $-0.17 | $-0.16 | $-0.15 | $-0.15 | $-1.89 | $-0.07 | $-0.06 | $-0.09 |
| EBITDA | -$50.5M | $4.4M | -$32.9M | -$56.1M | -$63.2M | -$58.7M | -$53.0M | -$48.2M | -$470.1M | -$20.1M | -$20.1M | -$26.5M |
| Operating cash flow | -$43.0M | $5.1M | -$29.7M | -$52.9M | -$48.2M | -$42.6M | -$46.3M | -$31.1M | -$37.3M | -$15.7M | -$15.0M | -$16.2M |
| Free cash flow | -$43.2M | $5.0M | -$29.8M | -$60.9M | -$48.4M | -$42.7M | -$46.3M | -$31.2M | -$37.3M | -$15.7M | -$15.0M | -$16.2M |
| Diluted shares | 348.8M | 377.5M | 344.4M | 342.4M | 340.7M | 338.6M | 337.7M | 273.6M | 244.7M | 219.0M | 219.0M | 218.9M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $258.6M | $125.4M | $164.1M | $98.9M | $248.0M | $48.0M |
| Short-term investments | $402.4M | $408.3M | $365.1M | $450.1M | $359.8M | $413.7M |
| Total debt | $261.5M | $53.1M | $62.5M | $52.7M | $55.4M | $5.7M |
| Total assets | $744.5M | $610.2M | $594.8M | $601.6M | $647.2M | $492.5M |
| Total liabilities | $490.6M | $290.7M | $289.1M | $275.7M | $274.3M | $73.0M |
| Shareholders' equity | $253.9M | $319.6M | $305.7M | $325.9M | $372.9M | $419.5M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology